Blocking histamine H1 improves learning and mnemonic dysfunction in mice with social isolation plus repeated methamphetamine injection

Journal of Pharmacological Sciences

Volumn 107, Issue 2, 2008, Pages 167-174

  Jia, Feiyong ^a,b   Mobarakeh, Jalal Izadi ^a,c   Dai, Hongmei ^a   Kato, Motohisa ^a   Xu, Ajing ^a   Okuda, Tomohiro ^a   Sakurai, Eiko ^a   Okamura, Nobuyuki ^a   Takahashi, Kazuhiro ^a   Yanai, Kazuhiko ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

H1 receptor; Histamine; Memory; Methamphetamine; Social isolation

Indexed keywords

CLOZAPINE; DONEPEZIL; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; MEPYRAMINE; METHAMPHETAMINE; THIOPERAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RESEARCH; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PREPULSE INHIBITION; RECOGNITION; SOCIAL ISOLATION; TASK PERFORMANCE;

EID: 46449112326     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0072424     Document Type: Article

References (31)

1. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984;295:13-25.
2. Yanai K, Son LZ, Endou M, Sakurai E, Nakagawasai O, Tadano T, et al. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience. 1998;87:479-487.
3. Yanai K, Watanabe T. Histamine as a neurotransmitter in the central nervous system. In: Falus A, Grosman N, Darvas Zs, editors. Histamine: biology and medical aspects. SpringMed Publishing and S. Karger AG; 2004. p. 251-263.
4. Kuramasu A, Sukegawa J, Yanagisawa T, Yanai K. Recent advances in molecular pharmacology of the histamine systems: roles of C-terminal tails of histamine receptors. J Pharmacol Sci. 2006;101:7-11.
5. Yanai K, Okamura N, Tagawa M, Itoh M, Watanabe T. New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice. Clin Exp Allergy. 1999;29 Suppl 3:29-36.
6. Chen Z, Kamei C. Facilitating effects of histamine on spatial memory deficit induced by scopolamine in rats. Acta Pharmacol Sin. 2000;21:814-818.
7. Meguro K, Yanai K, Sakai N, Sakurai E, Maeyama K, Sasaki H, et al. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence- accelerated mice. Pharmacol Biochem Behav. 1995;50:321-325.
8. Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol. 1996;6 Suppl 2:S13-S20.
9. Levin ED, Wilson W, Rose JE, McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology. 1996;15:429-436.
10. Addy N, Levin ED. Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology. 2002;27:534-541.
11. Addy NA, Pocivavsek A, Levin ED. Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions. Neuropsychopharmacology. 2005;30:1121-1127.
12. Dai H, Okuda H, Iwabuchi K, Sakurai E, Chen Z, Kato M, et al. Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine. Ann N Y Acad Sci. 2004;1025:257-266.
13. Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology. 2005;30:213521-213543.
14. Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA. Efficacy and tolerability of low-dose donepezil in schizophrenia. Clin Neuropharmacol. 2005;28:179-184.
15. Jia F, Kato M, Dai H, Xu A, Okuda T, Sakurai E, et al. Effects of histamine H(3) antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice. Neuropharmacology. 2006;50:404-411.
16. Roegge CS, Perraut C, Hao X, Levin ED. Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. Pharmacol Biochem Behav. 2007;86:686-692.
17. Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A. Performance of different mouse strains in an object recognition task. Behav Brain Res. 2003;147:49-54.
18. Ventura R, Pascucci T, Catania MV, Musumeci SA, Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol. 2004;15:433-442.
19. Ito C, Onodera K, Watanabe T, Sato M. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats. Psychopharmacology (Berl). 1997;130:362-367.
20. Morisset S, Pilon C, Tardivel-Lacombe J, Weinstein D, Rostene W, Betancur C, et al. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. J Pharmacol Exp Ther. 2002;300:621-628.
21. Rauscher FP, Nasrallah HA, Wyatt RJ. Cutaneous histamine response in schizophrenia. J Clin Psychiatry. 1980;41:44-51.
22. Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, et al. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995;14:93-104.
23. Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, et al. Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiatry. 1991;30:349-356.
24. Iwabuchi K, Ito C, Tashiro M, Kato M, Kano M, Itoh M, et al. Histamine H1 receptors in schizophrenic patients measured by positron emission tomography. Eur Neuropsychopharmacol. 2005;15:185-191.
25. Tollefson GD. Cognitive function in schizophrenic patients. J Clin Psychiatry. 1996;57 Suppl 11:31-39.
26. Stip E, Chouinard S, Boulay LJ. On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:219-232.
27. Weinberger DR, Gallhofer B. Cognitive function in schizophrenia. Int Clin Psychopharmacol. 1997;12 Suppl 4:S29-S36.
28. Moragrega I, Carrasco MC, Vicens P, Redolat R. Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration. Behav Brain Res. 2003;147:1-8.
29. Võikar V, Polus A, Vasar E, Rauvala H. Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav. 2005;4:240-252.
30. Quirk GJ, Russo GK, Barron JL, Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci. 2000;20:6225-6231.
31. Blandina P, Efoudebe M, Cenni G, Mannaioni P, Passani MB. Acetylcholine, histamine, and cognition: two sides of the same coin. Learn Mem. 2004;11:1-8.